Our work was awarded Gold Medal (Original Research by Trainees) by the HK Academy of Medicine for 3 straight years🥇🥇🥇Carrying this momentum into 2026!
ft. my girl who likes the gold but always disturbs my work
MFYuen @WK_Seto@jamesyyfung@loeymak@hkudeptmedicine@hkumed
Celebrating a fruitful weekend where I received my Hong Kong College of Physicians fellowship, the Gold Medal for best thesis, and a Distinguished paper award
Also congratulations to @loeymak, @JimmyLaiCT and Michael Cheung for their great papers!
@hkudeptmedicine@hkumed
We studied HBV integration patterns in different disease phases. Integrations associated with HCC were observed regardless of hepatitis activity, viremia level, and HBsAg positivity
Another reason to expand NUC treatment indication?
@WK_Seto@jamesyyfung@loeymak@hkumed
🟣Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatment
🔓#OpenAccess at👉https://t.co/7EsfwrCEVU
#HBV#LiverX#LiverTwitter
We studied Days At Home (DAH) reflecting the disease time burden. Immunotherapy gives HCC patients more DAH than tyrosine kinase inhibitor treatment. https://t.co/JQHQOcM1Dk
Congratulations to @RexWHHui@MattChungHKU@CarlosWongHKU @Ian_HKU @hkumed@JHEP_Reports
Celebrating my PhD graduation with my supervisor Professor MF Yuen, and @WK_Seto@IvanHung2@loeymak
Happy to wrap up this chapter and looking forward to more exciting science ahead
@hkumed@hkudeptmedicine
HKUMed researchers have started clinical trials exploring a pioneering gene-related therapy for chronic hepatitis B infection, potentially allowing patients to stop long-term medication.
For more: https://t.co/r0FsNVHAgQ
A new article in Hepatology International examines emerging therapies for HBsAg seroclearance, with a focus on innovative novel combination strategies that hold promise for functional cure. This comprehensive review offers critical insights for clinicians and researchers alike.
🔗 Read the full article here: https://t.co/nUS0xCt5AT
#Hepatology #HepatitisB #HBsAgSeroclearance #NovelTherapies #CombinationTherapy #MedicalResearch #LiverHealth #HepatologyInternational #HealthcareProfessionals
Our work has been awarded Gold Medal – Best Original Research by Trainees by The Hong Kong Academy of Medicine for the 2nd straight year🥇🥇
Grateful for 2024, and looking forward to a fruitful 2025!
Prof MF Yuen, @WK_Seto, @jamesyyfung , @loeymak@hkumed@hkudeptmedicine
Our paper described the longitudinal profile of blood levels of HBV pregenomic RNA in CHB 🦠patients treated with long term NUC 💊now in press @CMH_journal
https://t.co/WpJdkpw3ZL
Clinical parameters eg age, gender, PAGE-B score and HBeAg can influence pgRNA levels #mfyuen
Our paper on ALT/qHBsAg after stopping ETV has been awarded the Young Investigator Medal by the Hong Kong College of Physicians
Thankful as always to Professor MF Yuen, @WK_Seto@jamesyyfung@loeymak for their tremendous support
Full paper
https://t.co/iaSVZpOuOV
#GUTAbstract by Mao et al on
"Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study" via https://t.co/uA32k1nwpr
Paper: https://t.co/vpBwqtmcvM
@WK_Seto@CheungKaShingM2@hkumed@HKUniversity